氧化三甲胺与老年慢性心力衰竭相关性的研究进展

doi:10.3969/j.issn.1003-9198.2022.01.024

[1] 吴丽馨,马丽芳,王双,等.老年人肠道微生态与心力衰竭相关性的研究[J].中华老年医学杂志, 2020, 39(7):850-852.
[2] ADAK A, KHAN M R. An insight into gut microbiota and its functionalities[J].Cell Mol Life Sci, 2019, 76(3): 473-493.
[3] MANASA J S, TALUKDAR R, SUBRAMANYAM C, et al. Role of the normal gut microbiota[J]. World J Gastroentero, 2015, 21(29): 8787-803.
[4] 张炳山,郁志明,洪侃.衰弱与肠道微生物[J].实用老年医学, 2020, 34(6): 617-623.
[5] TICINESI A, TANA C, NOUVENNE A, et al. The intestinal microbiome and its relevance for functionality in older persons[J]. Curr Opin Clin Nutr Metab Care, 2019, 22(1): 4-12.
[6] SALAZAR N, VALDÉS-VARELA L, GONZÁLEZ S, et al. Nutrition and the gut microbiome in the elderly[J]. Gut Microbes, 2017, 8(2): 82-97.
[7] POLSINELLI V B, SINHA A, SHAH S J. Visceral congestion in heart failure: right ventricular dysfunction, splanchnic hemodynamics, and the intestinal microenvironment[J]. Curr Heart Fail Rep, 2017, 14(6): 519-528.
[8] GIL-CRUZ C, PEREZ-SHIBAYAMA C, MARTIN A D, et al. Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy[J]. Science, 2019, 366(6467): 881-886.
[9] 李飞翔,赵阳.老年冠心病合并心力衰竭患者肠道菌群特征性研究[J].中华老年医学杂志, 2019, 38(11):1220-1222.
[10] HAYASHI T, YAMASHITA T, WATANABE H,et al. Gut microbiome and plasma microbiome-related metabolites in patients with decompensated and compensated heart failure[J]. Circ J, 2019, 83(1): 182-192.
[11] ZHOU H, QIAN H. Relationship between enteral nutrition and serum levels of inflammatory factors and cardiac function in elderly patients with heart failure[J].Clin Interv Aging, 2018, 13:397-401.
[12] CHIONCEL O, AMBROSY A P. Trimethylamine N‐oxide and risk of heart failure progression: marker or mediator of disease[J]. Eur J Heart Fail, 2019, 21(7): 887-890.
[13] JENS O, ABITZ W S, SCHMIDT H T, et al. Trimethylamine N-oxide (TMAO) as a new potential therapeutic target for insulin resistance and cancer[J]. Curr Pharm Des, 2017, 23(25): 3699-3712.
[14] TANG W H. We are not alone: understanding the contributions of intestinal microbial communities and the congested gut in heart failure[J]. Jacc Heart Failure, 2016, 4(3): 228-229.
[15] YANG W, ZHANG S, ZHU J, et al. Gut microbe-derived metabolite trimethylamine N-oxide accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis[J]. J Mol Cell Cardiol, 2019, 134:119-130.
[16] TANG W H, WANG Z, FAN Y, et al. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis[J]. J Am Coll Cardiol, 2014, 64(18): 1908-1914.
[17] YUE C, YANG X, LI J, et al. Trimethylamine N-oxide prime NLRP3 inflammasome via inhibiting ATG16L1-induced autophagy in colonic epithelial cells[J]. Biochem Biophys Res Commun, 2017, 490(2): 541-551.
[18] WANG Z, ROBERTS A B, BUFFA J A, et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis[J]. Cell, 2015, 163(7): 1585-1595.
[19] DIN A U, HASSAN A, ZHU Y, et al. Amelioration of TMAO through probiotics and its potential role in atherosclerosis[J]. Appl Microbiol Biotechnol, 2019, 103(23-24): 9217-9228.
[20] 李伟,赵翠,王国玉,等. 肠内营养对老年慢性心力衰竭病人营养状态、心功能及炎性因子的影响[J].实用老年医学, 2019, 33(7): 646-649.
[21] 杨云梅.老年肠道微生态新进展[J].中华保健医学杂志, 2016, 18(1):1-6.
[22] LIU J, LIT X,WU H, et al. Lactobacillus rhamnosus GG strain mitigated the development of obstructive sleep apnea-induced hypertension in a high salt diet via regulating TMAO level and CD4+ T cell induced-type I inflammation[J]. Biomed Pharmacother, 2019, 112:108580.
[23] JIA Q, LI H, ZHOU H, et al. Role and effective therapeutic target of gut microbiota in heart failure[J]. Cardiovasc Ther, 2019, 2019:5164298.
[24] BU J, WANG Z H. Cross-talk between gut microbiota and heart via the routes of metabolite and immunity[J]. Gastroenterol Res Pract, 2018, 2018:6458094.
[25] CHEN X, LI H Y, HU X M, et al. Current understanding of gut microbiota alterations and related therapeutic intervention strategies in heart failure[J]. Chin Med J (Engl),2019, 132(15): 1843-1855.
[26] NAGATOMO Y, TANG W H W. Intersections between microbiome and heart failure: revisiting the gut hypothesis[J]. J Card Fail, 2015, 21(12): 973-980.
[27] ASCHER S, REINHARDT C. The gut microbiota: an emerging risk factor for cardiovascular and cerebrovascular disease[J]. Eur J Immunol, 2018, 48(4): 564-575.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Recommended 10

[1]	. [J]. Practical Geriatrics, 2024, 38(10): 979-982.
[2]	GU Chonghuai, XIANG Xuejun, ZHENG Yuanxi, QIAO Rui, LIN Song. Efficacy of dapagliflozin in elderly patients undergoing coronary intervention with type 2 diabetes mellitus and ejection fraction reduced heart failure [J]. Practical Geriatrics, 2024, 38(10): 1025-1029.
[3]	LIU Jin, HUANG Yanqiu, ZHU Yi, ZHUO Lili. Effects of sacubitril valsartan sodium in elderly patients with chronic heart failure [J]. Practical Geriatrics, 2024, 38(10): 1030-1033.
[4]	XU Shouyong, YUAN Yong. Study on feasibility of dual-low-dose CT coronary angiography in elderly patients [J]. Practical Geriatrics, 2024, 38(10): 1054-1058.
[5]	LIU Lin, WU Qing, ZHANG Jing, MAO Fangying, YU Lu, REN Yiting, FANG Ting. Status and influencing factors of symptom perception in elderly patients with heart failure [J]. Practical Geriatrics, 2024, 38(5): 461-437.
[6]	LIU Qianhui, YAO Zijun, HE Yuli, XU Yunfan, WU Jun. Effects of HbA1c level on cardiac structure and function in elderly patients with type 2 diabetes mellitus and chronic heart failure [J]. Practical Geriatrics, 2024, 38(5): 491-437.
[7]	ZHANG Lili, LI Jing, DING Linfeng, SUN Jingxian, CAI Jingbo. Predictive value of carotid atherosclerosis plaque for ischemic stroke events in patients with nonvalvular atrial fibrillation [J]. Practical Geriatrics, 2024, 38(3): 236-239.
[8]	ZHA Zhimin, LIU Huan, WANG Xiangming, LI Qiushuang, GUO Yan. Effect of cardiac valve calcification on prognosis of elderly patients with coronary heart disease [J]. Practical Geriatrics, 2024, 38(3): 245-250.
[9]	. [J]. Practical Geriatrics, 2024, 38(3): 308-311.
[10]	CHENG Qing, XU Yan, CHEN Guofei, DENG Xinyue. Correlation of serum angiotensin Ⅱ and nitric oxide levels with cognitive dysfunction in elderly patients with chronic heart failure [J]. Practical Geriatrics, 2024, 38(2): 132-135.
[11]	ZHANG Ying, XIE Ling, YE Jiaqi, QIANG Wenhui, YAN Xiaoyun, JIANG Ying, ZHANG Qing. Correlation between laminin and major adverse cardiovascular events in elderly patients with acute myocardial infarction [J]. Practical Geriatrics, 2024, 38(2): 149-151.
[12]	REN Li-yan. Correlation between serum cholinesterase and ventricular remodeling in elderly patients with heart failure [J]. Practical Geriatrics, 2023, 37(12): 1238-1241.
[13]	. [J]. Practical Geriatrics, 2023, 37(12): 1270-1273.
[14]	LU Hao, DENG Hui, WANG Chun, DAI Yang, WANG Qin, WANG Qing. Characteristics of cardiopulmonary function, exercise endurance, and the levels of NT-proBNP and TNT in elderly patients with stable chronic heart failure [J]. Practical Geriatrics, 2023, 37(11): 1138-1142.
[15]	YANG Xue, NING Chun, ZHAO Juan, HAO Jing-bo, YANG Rong-li. Diagnostic value of growth differentiation factor 15 and cytokines in elderly patients with coronary heart disease complicated with frailty [J]. Practical Geriatrics, 2023, 37(10): 1009-1013.